The Type 2 Diabetes and the Risk of Inflammatory Bowel Disease Utilizing Propensity Score Methods for Risk Factors’ Screening and Balancing between Type 2 Diabetes and Non-Diabetes Population in Risk of IBD Assessment
Exposure to Tricyclic and Selective Serotonin Reuptake Inhibitor Antidepressants and the Risk of Hip Fracture: An Updated US-Based Case-Control Study
Prediction of Non-Response to First-Line Methotrexate Treatment in Rheumatoid Arthritis: A Real-World Data Analysis Using Machine Learning
Prediction of Major Adverse Cardiovascular Events Among Type 2 Diabetes Mellitus Patients: A Machine Learning Time to Event Analysis
Real-World Data Analysis of Second-Line Antiangiogenic Targeted Treatments Following Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies and First-Line FOLFOX for Patients with Metastatic Colorectal Cancer
Reduction in Diabetes-Related Hospitalization Rates After Real-Time Continuous Glucose Monitor (RTCGM) Initiation
